KumarNAbboudH. Iatrogenic CNS demyelination in the era of modern biologics. Mult Scler25: 1079–1085.
2.
RekhiEPryceASohalM, et al. CNS demyelination in patients on nilotinib treatment for CML. J Neurol Neurosurg Psychiatry2016; 87: 12.
3.
Kalinowska-LyszczarzAEsfahaniMFGuoY, et al. Pathological findings in central nervous system demyelination associated with infliximab. Mult Scler2020; 26: 1124–1128.
4.
RotsteinDLSawickaKBharathaA, et al. CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases. Mult Scler2020; 26: 1121–1124.
5.
MontalbanXArnoldDLWeberMS, et al. Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis. N Engl J Med2019; 380: 2406–2417.
